Transition Therapeutics Company Culture
Transition Therapeutics Culture
This score is derived from employee ratings & reviewsTop Rated Culture Dimensions
Share Your Opinion
Anonymously Rate Your Experience & Make Work BetterTransition Therapeutics Company Information
Transition Therapeutics Company Overview
Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.
| Headquarter | 101 College Street, Suite 220 Toronto, KS United States of America |
|---|---|
| Website | transitiontherapeutics.com |
| Founding Date | 1998 |
| Tel | 416-260-7770 |
| Company Status | Public |
Transition Therapeutics Competitors
Transition Therapeutics competitors include Sage Therapeutics and Voyager Therapeutics. See below how Transition Therapeutics compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.
Transition Therapeutics Careers
Transition Therapeutics Jobs
No Recent Jobs found for Transition Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably
Let Transition Therapeutics Know You Want To Work There
Frequently Asked Questions regarding Transition Therapeutics
What is Transition Therapeutics address?
Transition Therapeutics location is at 101 College Street, Suite 220
Who are Transition Therapeutics competitors?
Transition Therapeutics main competitors are Sage Therapeutics, Voyager Therapeutics
Who is Transition Therapeutics leadership?
are part of Transition Therapeutics leadership, Tony Cruz is the CEO
×